2-[6-(4-acetylpiperazin-1-yl)-4-oxo-1,2,4a,5,6,7,8,8a-octahydroquinazolin-3-yl]-N-[(4-chlorophenyl)methyl]acetamide
C23H32ClN5O3 — CID 155818270
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-[6-(4-acetylpiperazin-1-yl)-4-oxo-1,2,4a,5,6,7,8,8a-octahydroquinazolin-3-yl]-N-[(4-chlorophenyl)methyl]acetamide
2-[6-(4-acetylpiperazin-1-yl)-4-oxo-1,2,4a,5,6,7,8,8a-octahydroquinazolin-3-yl]-N-[(4-chlorophenyl)methyl]acetamide (PubChem CID 155818270) has the molecular formula C23H32ClN5O3 and a molecular weight of 461.99 g/mol. Its IUPAC name is 2-[6-(4-acetylpiperazin-1-yl)-4-oxo-1,2,4a,5,6,7,8,8a-octahydroquinazolin-3-yl]-N-[(4-chlorophenyl)methyl]acetamide.
Molecular Properties
| Compound Name | 2-[6-(4-acetylpiperazin-1-yl)-4-oxo-1,2,4a,5,6,7,8,8a-octahydroquinazolin-3-yl]-N-[(4-chlorophenyl)methyl]acetamide |
|---|---|
| PubChem CID | 155818270 |
| Molecular Formula | C23H32ClN5O3 |
| Molecular Weight | 461.99 g/mol |
| Exact Mass | 461.22 |
| IUPAC Name | 2-[6-(4-acetylpiperazin-1-yl)-4-oxo-1,2,4a,5,6,7,8,8a-octahydroquinazolin-3-yl]-N-[(4-chlorophenyl)methyl]acetamide |
| SMILES | CC(=O)N1CCN(C2CCC3NCN(CC(=O)NCc4ccc(Cl)cc4)C(=O)C3C2)CC1 |
| InChI | InChI=1S/C23H32ClN5O3/c1-16(30)27-8-10-28(11-9-27)19-6-7-21-20(12-19)23(32)29(15-26-21)14-22(31)25-13-17-2-4-18(24)5-3-17/h2-5,19-21,26H,6-15H2,1H3,(H,25,31) |
| InChIKey | WYNWJYRPKIZREP-UHFFFAOYSA-N |
| XLogP | 1.05 |
| TPSA | 84.99 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 32 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 461.99 |
| LogP ≤ 5 | 1.05 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 155818270 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.